These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8077896

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Assessment of a multiple-dose drug interaction between ezetimibe, a novel selective cholesterol absorption inhibitor and gemfibrozil.
    Reyderman L, Kosoglou T, Statkevich P, Pember L, Boutros T, Maxwell SE, Affrime M, Batra V.
    Int J Clin Pharmacol Ther; 2004 Sep; 42(9):512-8. PubMed ID: 15487810
    [Abstract] [Full Text] [Related]

  • 23. Beneficial effects of fish liver preparations of sea bass (Lates calcarifer) versus gemfibrozil in high fat diet-induced lipid-intolerant rats.
    Rizvi F, Iftikhar M, George JP.
    J Med Food; 2003 Sep; 6(2):123-8. PubMed ID: 12935323
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of gemfibrozil (Lopid) on hyperlipidemia in acitretin-treated patients. Results of a double-blind cross-over study.
    Vahlquist C, Olsson AG, Lindholm A, Vahlquist A.
    Acta Derm Venereol; 1995 Sep; 75(5):377-80. PubMed ID: 8615057
    [Abstract] [Full Text] [Related]

  • 26. Comparison in patients with type 2 diabetes of fibric acid versus hepatic hydroxymethyl glutaryl-coenzyme a reductase inhibitor treatment of combined dyslipidemia.
    McLaughlin T, Abbasi F, Lamendola C, Leary E, Reaven GM.
    Metabolism; 2002 Oct; 51(10):1355-9. PubMed ID: 12370858
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Evaluation of the therapeutic efficacy of pravastatin in monothereapy and in association with gemfibrozil in hypercholesterolemia associated with moderate hyperglyceridemia].
    Napoli C, Lepore S, Ambrosio G, Chiariello M.
    Cardiologia; 1992 Nov; 37(11):761-8. PubMed ID: 1298545
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [A long-term study on blood lipids after gemfibrozil].
    Lu Z.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):369-71. PubMed ID: 1821353
    [No Abstract] [Full Text] [Related]

  • 33. [The effects of Xuezhikang on serum lipid profile, thromboxane A2 and prostacyclin in patients with hyperlipidemia].
    Jian J, Hao X, Deng C, Zhou H, Lin J.
    Zhonghua Nei Ke Za Zhi; 1999 Aug; 38(8):517-9. PubMed ID: 11798687
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Gemfibrozil treatment potentiates oxidative resistance of high-density lipoprotein in hypertriglyceridemic patients.
    Chen MF, Wang TD, Yeh HT, Hsu HC, Lee YT.
    Eur J Clin Invest; 2001 Aug; 31(8):707-13. PubMed ID: 11473572
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study.
    Manninen V, Huttunen JK, Heinonen OP, Tenkanen L, Frick MH.
    Am J Cardiol; 1989 May 02; 63(16):42H-47H. PubMed ID: 2650524
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.